1-(2-chloropyridin-4-yl)-3-(4-methylthiazol-2-yl)urea

ID: ALA4282784

PubChem CID: 145980671

Max Phase: Preclinical

Molecular Formula: C10H9ClN4OS

Molecular Weight: 268.73

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1csc(NC(=O)Nc2ccnc(Cl)c2)n1

Standard InChI:  InChI=1S/C10H9ClN4OS/c1-6-5-17-10(13-6)15-9(16)14-7-2-3-12-8(11)4-7/h2-5H,1H3,(H2,12,13,14,15,16)

Standard InChI Key:  APFPJIWYBJHIHN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
   16.2805   -3.6814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2794   -4.5010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9874   -4.9100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6971   -4.5005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6942   -3.6779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9856   -3.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9832   -2.4554    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   18.4054   -4.9080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1125   -4.4983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8208   -4.9058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1112   -3.6811    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5266   -3.6789    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.5295   -4.4925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3043   -4.7413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7802   -4.0813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2996   -3.4248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5974   -4.0783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 13  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
 15 17  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4282784

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 268.73

Molecular Weight (Monoisotopic): 268.0186

AlogP: 3.14

#Rotatable Bonds: 2

Polar Surface Area: 66.91

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.33

CX Basic pKa: 1.58

CX LogP: 2.20

CX LogD: 1.88

Aromatic Rings: 2

Heavy Atoms: 17

QED Weighted: 0.82

Np Likeness Score: -2.90

References

1. Papillon JPN, Nakajima K, Adair CD, Hempel J, Jouk AO, Karki RG, Mathieu S, Möbitz H, Ntaganda R, Smith T, Visser M, Hill SE, Hurtado FK, Chenail G, Bhang HC, Bric A, Xiang K, Bushold G, Gilbert T, Vattay A, Dooley J, Costa EA, Park I, Li A, Farley D, Lounkine E, Yue QK, Xie X, Zhu X, Kulathila R, King D, Hu T, Vulic K, Cantwell J, Luu C, Jagani Z..  (2018)  Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.,  61  (22): [PMID:30339381] [10.1021/acs.jmedchem.8b01318]

Source

Source(1):

• Scientific Literature